NEW YORK (GenomeWeb) – Alere today announced that its shareholders have voted to approve the company's acquisition by Abbott. Alere said that more than 98 percent of the votes cast at a special meeting — representing 77 percent of outstanding Alere shares on Aug. 26 — voted in favor of the acquisition.

"The overwhelming support we received from our shareholders today is recognition of the significant value that the combination of Alere and Abbott unlocks for our global customers, employees, and shareholders," Alere President and CEO Namal Nawana said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.